Target intelligence / Profile preview

Pathogenic intestinal bacteria and intestinal epithelium

Molecular classification
Other
01

Overview

The term Pathogenic intestinal bacteria and intestinal epithelium refers to the complex biological interface where enteric pathogens interact with the host's mucosal lining. The intestinal epithelium serves as a critical physical and immunological barrier, utilizing tight junctions to prevent the translocation of bacteria into the systemic circulation (StatPearls, 2024). Pathogenic bacteria, such as Salmonella and Escherichia coli, employ virulence factors to adhere to and invade these epithelial cells, often triggering an inflammatory cascade (Nature Reviews Microbiology, 2021). This interaction is the primary site of action for various therapeutic interventions, including non-systemic antibiotics like Rifaximin and probiotics intended to restore microbial balance (NIH, 2023). Because this entry describes a multi-component biological system rather than a single molecular entity, it is classified as a system-level interaction rather than a discrete therapeutic target (PubMed, 2022). Understanding this relationship is essential for treating enteric infections and managing chronic conditions like inflammatory bowel disease where barrier integrity is compromised.

Other names
Gut-pathogen interfaceIntestinal host-pathogen interactionEnteric bacterial infectionIntestinal mucosal barrier
02

Mechanism of action

Inhibition of bacterial protein synthesis or DNA replication, disruption of bacterial cell membranes, and competitive exclusion by beneficial microbes to protect the epithelial barrier.

03

Biological functions

Immune responseBarrier functionInfectionHomeostasis
04

Disease associations

InfectionInflammationInflammatory bowel diseaseDiarrheal disease
05

Safety considerations

Antibiotic resistanceGut dysbiosisClostridioides difficile overgrowthSystemic side effects of antibiotics
06

Interacting drugs

Rifaximin

4 more in the full profile.

07

Biomarkers

Fecal calprotectinFecal lactoferrinStool cultureC-reactive protein

Beyond the preview

Go deeper on Pathogenic intestinal bacteria and intestinal epithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic intestinal bacteria and intestinal epithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call